Segall Bryant & Hamill’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,910
Closed -$220K 715
2023
Q1
$220K Sell
18,910
-20,000
-51% -$255K ﹤0.01% 685
2022
Q4
$413K Sell
38,910
-14,200
-27% -$137K ﹤0.01% 599
2022
Q3
$516K Buy
53,110
+28,300
+114% +$375K 0.01% 573
2022
Q2
$359K Sell
24,810
-13,416
-35% -$229K ﹤0.01% 633
2022
Q1
$1M Sell
38,226
-492,511
-93% -$14M 0.01% 517
2021
Q4
$21.1M Sell
530,737
-86,495
-14% -$3.94M 0.19% 136
2021
Q3
$31M Buy
617,232
+8,951
+1% +$488K 0.3% 95
2021
Q2
$33.8M Buy
608,281
+90,356
+17% +$4.81M 0.33% 86
2021
Q1
$24.2M Buy
+517,925
New +$25.1M 0.24% 117

Other funds holding HCAT